Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Hiroshi, Uchiya"'
Autor:
Shinpei Yamaba, Yukinori Imai, Kayoko Sugawara, Yoshihito Uchida, Akira Fuchigami, Hiroshi Uchiya, Nobuaki Nakayama, Satoshi Mochida
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0298770 (2024)
AimTo clarify the efficacy of atezolizumab (ATZ) plus bevacizumab (BEV) as the second-line therapy for patients with unresectable hepatocellular carcinoma (HCC).MethodsThe subjects were 82 patients with HCC receiving ATZ/BEV, including 33 patients wi
Externí odkaz:
https://doaj.org/article/8812e3f451694156a06fd5997bd55d92
Autor:
Manabu Nakazawa, Yukinori Imai, Kayoko Sugawara, Yoshihito Uchida, Yoichi Saitoh, Yohei Fujii, Hiroshi Uchiya, Satsuki Ando, Nobuaki Nakayama, Tomoaki Tomiya, Satoshi Mochida
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Aim To establish a therapeutic strategy for cirrhosis patients with gastric variceal bleeding. Methods The outcomes of 137 patients with bleeding gastric varices were evaluated. Results The bleeding source was gastroesophageal varices (GOV) in 86 pat
Externí odkaz:
https://doaj.org/article/d32aa34a0db14e459e3d9c8543e6dc75
Autor:
Akira Fuchigami, Yukinori Imai, Yoshihito Uchida, Hiroshi Uchiya, Yohei Fujii, Manabu Nakazawa, Satsuki Ando, Kayoko Sugawara, Nobuaki Nakayama, Tomoaki Tomiya, Satoshi Mochida
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231427 (2020)
AIM:This study sought to clarify the usefulness of lenvatinib for patients with unresectable hepatocellular carcinoma (HCC). METHODS:The subjects were 69 patients with HCC receiving lenvatinib; the median age was 73 years, and 14 and 67 patients had
Externí odkaz:
https://doaj.org/article/d953b0efae3747dcb54da2e12f2cccbf
Autor:
Aya, Sato, Yukinori, Imai, Hiroshi, Uchiya, Yoshihito, Uchida, Manabu, Nakazawa, Kayoko, Sugawara, Nobuaki, Nakayama, Satoshi, Mochida
Publikováno v:
Internal Medicine. 61:2301-2305
We herein report two patients with hepatocellular carcinoma (HCC) who exhibited intraabdominal bleeding caused by tumor rupture soon after lenvatinib initiation. A hypervascular nodule was present in the lateral segment manifesting extrahepatic protr
Autor:
Manabu Nakazawa, Yukinori Imai, Kayoko Sugawara, Yoshihito Uchida, Yoichi Saitoh, Yohei Fujii, Hiroshi Uchiya, Satsuki Ando, Nobuaki Nakayama, Tomoaki Tomiya, Satoshi Mochida
Publikováno v:
PloS one. 17(3)
Aim To establish a therapeutic strategy for cirrhosis patients with gastric variceal bleeding. Methods The outcomes of 137 patients with bleeding gastric varices were evaluated. Results The bleeding source was gastroesophageal varices (GOV) in 86 pat
Autor:
Manabu Nakazawa, Kayoko Sugawara, Tomoaki Tomiya, Yukinori Imai, Nobuaki Nakayama, Satsuki Ando, Hiroshi Uchiya, Satoshi Mochida
Publikováno v:
JGH Open. 1:127-133
Aim Portosystemic shunts aggravate liver function by decreasing portal blood flow. The usefulness of balloon-occluded retrograde transvenous obliteration (B-RTO), a standardized therapeutic procedure for gastric fundal varices (GFV), for the improvem
Autor:
Manabu Nakazawa, Yukinori Imai, Yoichi Saito, Masamitsu Nakao, Yohei Fujii, Hayato Uemura, Satoshi Mochida, Yoshihito Uchida, Mie Inao, Tomoaki Tomiya, Kayoko Sugawara, Keisuke Shiokawa, Kayoko Naiki, Daisuke Motoya, Shinpei Yamaba, Nobuaki Nakayama, Satsuki Ando, Jun-ichi Kouyama, Hiroshi Uchiya, Akira Fuchigami
Publikováno v:
Hepatology Research. 48:233-243
Aim To improve the therapeutic efficacy of sofosbuvir/ledipasvir (SOF/LDV) for the retreatment of patients after daclatasvir/asunaprevir (DCV/ASV), a customized therapy with or without lead-in interferon (IFN)-β injections was formulated according t
Autor:
Yohei Fujii, Yukinori Imai, Satsuki Ando, Tomoaki Tomiya, Akira Fuchigami, Yoshihito Uchida, Kayoko Sugawara, Manabu Nakazawa, Hiroshi Uchiya, Satoshi Mochida, Nobuaki Nakayama
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231427 (2020)
PLoS ONE
PLoS ONE
Aim This study sought to clarify the usefulness of lenvatinib for patients with unresectable hepatocellular carcinoma (HCC). Methods The subjects were 69 patients with HCC receiving lenvatinib; the median age was 73 years, and 14 and 67 patients had
Autor:
Hayato, Uemura, Yoshihito, Uchida, Jun-Ichi, Kouyama, Kayoko, Naiki, Shinpei, Yamaba, Akira, Fuchigami, Yoichi, Saito, Keisuke, Shiokawa, Yohei, Fujii, Hiroshi, Uchiya, Manabu, Nakazawa, Satsuki, Ando, Masamitsu, Nakao, Daisuke, Motoya, Kayoko, Sugawara, Mie, Inao, Yukinori, Imai, Nobuaki, Nakayama, Tomoaki, Tomiya, Satoshi, Mochida
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 48(4)
To improve the therapeutic efficacy of sofosbuvir/ledipasvir (SOF/LDV) for the retreatment of patients after daclatasvir/asunaprevir (DCV/ASV), a customized therapy with or without lead-in interferon (IFN)-β injections was formulated according to th
Autor:
Kiyoko Yoshino, Yukinori Imai, Masashi Oka, Yoshihito Uchida, Yohei Fujii, Takahiro Handa, Hiroshi Uchiya, Kazuki Hirahara, Manabu Nakazawa, Taku Chikayama, Satsuki Ando, Kayoko Sugawara, Mie Inao, Nozomi Shinozuka, Hidekazu Kayano, Satoshi Mochida
Publikováno v:
Progress of Digestive Endoscopy. 83:114-115